Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of SHP2 inhibition on hepatic stellate cell transcriptome.

ABSTRACT: Effect of SHP2 inhibition on hepatic stellate cell transcriptome.

PROVIDER: PRJNA588282 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10417430_1.fastq.gz	Fastqsanger.gz
	SRR10417430_2.fastq.gz	Fastqsanger.gz
	SRR10417431_1.fastq.gz	Fastqsanger.gz
	SRR10417431_2.fastq.gz	Fastqsanger.gz
	SRR10417432_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Effect of SHP2 inhibition on hepatic stellate cell transcriptome.

Project description:Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. Primary human hepatic stellate cells were treated with PDGF or PDGF + SHP2 inhibitor. RNA was purified and submitted for sequencing to Mayo Clinic Genomics Core. After applying the filters FDR>0.05, Log2(FC)>1 and RPKM>15, we ended up with nearly 300 genes differentially regulated between the two conditions. Ingenuity Pathway Analysis revealed that Ostheoarthritis was the first pathway to be differentially regulated. From this pathway, REDD1 (DDIT4 transcript), an mTOR inhibitor, was further explored, especially in the context of extracellular vesicle release.

2019-11-08 | GSE140110 | GEO

Hepatic Stellate Cells inhibition induced by YAP deletion

Project description:Hepatic Stellate Cells inhibition induced by YAP deletion

| PRJNA873694 | ENA

Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis

Project description:We report the effect of TGFβ vs PDGF 2h treatment in hepatic stellate cells. We also report the effect of TGFβ treatment for 48h in human hepatic stellate cells.

2018-09-07 | GSE119606 | GEO

Effect of glycolysis on hepatic stellate cell transcriptome

Project description:Effect of glycolysis on hepatic stellate cell transcriptome

| PRJNA1088561 | ENA

Effect of OGT inhibition on the epigenome of human LX-2 hepatic stellate cells

Project description:Effect of OGT inhibition on the epigenome of human LX-2 hepatic stellate cells

| PRJNA1016369 | ENA

TLR4 or CD44 deficiency effect on hepatic stellate cells

Project description:Analysis of hepatic stellate cells isoltaed from wild-type, TLR4-/-, and CD44-/- mice. TLR4 and CD44 are major hyaluronic acid receptors. Results provide insight into the effects of TLR4 and CD44 loss in hepatic stellate cells.

2020-01-01 | GSE109200 | GEO

Early Mouse Hepatic Stellate Cell Activation

Project description:Early during culture of primary mouse HSCs gene expression changes. These expression alterations can be affected by treating cells with histone deacetylase inhibitor, valproic acid Primary mouse Hepatic stellate cells were cultured for short periods of time (4-16-64h) in presence or absence of valproic acid. Gene expression analysis (mouse Gene 1.0 ST arrays according to manufacturerM-bM-^@M-^Ys manual 701880Rev4 (Affymetrix, Santa Clara, CA)), in vitro stellate cell activation and inhibition of the activation by valproic acid treatment.

2014-01-01 | E-GEOD-51882 | biostudies-arrayexpress

Hepatic Stellate Cells inhibition induced by YAP deletion

Project description:Gene expression by bulk RNAseq in isolated mouse Hepatic Stellate Cells (HSC) YAP ko compared to HSC YAP floxed (wt).

2022-08-26 | GSE212042 | GEO

TLR4 or CD44 deficiency effect on hepatic stellate cells

Project description:TLR4 or CD44 deficiency effect on hepatic stellate cells

| PRJNA430098 | ENA

Effect of TET2 deficient immune cells on hepatic stellate cell activation in vitro [coculture]

Project description:To investigate the role of Tet2 deficient immune cells in hepatic stellate cell activation, wild type or Tet2 deficient B cells, T cells, and hepatic macrophages were isolated and co-cultured with purified hepatic stellate cells. Gene expression profiling analysis of bulk hepatic stellate cell RNA was then performed.

2023-02-07 | GSE223693 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data